Trajectories of Serum Hepatitis B Surface antigen (HBsAg) During Treatment and Association With HBsAg Loss in Children With Hepatitis B e Antigen–Positive Chronic Hepatitis B: A Latent Class Trajectory Analysis
The Journal of Infectious Diseases · 2025
DOI: 10.1093/infdis/jiae349 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von Zhenzhen Yao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Maternal and Child Health, Xiangya School of Public Health, Central South University, Changsha, China. Hauptthemen laut MEDLINE: Hepatitis B Surface Antigens, Hepatitis B, Chronic, Hepatitis B e Antigens, Antiviral Agents. Die Arbeit nennt 33 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hunan Province, China.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Changes in serum hepatitis B surface antigen (HBsAg) during treatment are associated with HBsAg loss. However, little is known about the trajectory patterns of HBsAg in early treatment and their relationship to subsequent HBsAg loss.
Methods
A retrospective study was conducted on 166 treatment-naive children with hepatitis B e antigen (HBeAg)–positive chronic hepatitis B (CHB). Latent class trajectory analysis was used to identify trajectory groups of serum HBsAg. Cox proportional hazards models were used to assess the association between HBsAg trajectory groups and HBsAg loss.
Results
The median follow-up time was 20.70 (interquartile range, 12.54–34.17) months, and HBsAg loss occurred in 70 (42.17%) of all study participants. Using latent class trajectory analysis, HBeAg-positive patients with CHB were classified into 3 trajectory groups: trajectory 1 (sustained stability, 24.70%), trajectory 2 (slow decline, 38.55%), and trajectory 3 (rapid decline, 36.75%), respectively. The risk of achieving HBsAg loss was higher in both trajectory 2 (hazard ratio, 3.65 [95% confidence interval, 1.70–7.83]) and trajectory 3 (7.27 [3.01–17.61]), respectively.
Conclusions
Serum HBsAg levels during early treatment can be classified into distinct trajectory groups, which may serve as an additional predictive indicator for HBsAg loss in HBeAg-positive children with CHB.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Maternal and Child Health, Xiangya School of Public Health, Central South University, Changsha, China.
- NHC Key Laboratory of Birth Defect for Research and Prevention, Hunan Provincial Maternal and Child Health Care Hospital, Hunan, China.
ORCID-Profile: Songxu Peng
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hunan Province, China
Zitieren
APA
Yao, Z., Gu, Y., Lai, X., Yang, M., Xu, Y., Luo, J., & Peng, S. (2025). Trajectories of Serum Hepatitis B Surface antigen (HBsAg) During Treatment and Association With HBsAg Loss in Children With Hepatitis B e Antigen–Positive Chronic Hepatitis B: A Latent Class Trajectory Analysis. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiae349
Vancouver
Yao Z, Gu Y, Lai X, Yang M, Xu Y, Luo J, et al. Trajectories of Serum Hepatitis B Surface antigen (HBsAg) During Treatment and Association With HBsAg Loss in Children With Hepatitis B e Antigen–Positive Chronic Hepatitis B: A Latent Class Trajectory Analysis. The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiae349
BibTeX
@article{Yao2025,
author = {Yao, Zhenzhen and Gu, Yingping and Lai, Xin and Yang, Meng and Xu, Yi and Luo, Jiayou and Peng, Songxu},
title = {Trajectories of Serum Hepatitis B Surface antigen (HBsAg) During Treatment and Association With HBsAg Loss in Children With Hepatitis B e Antigen–Positive Chronic Hepatitis B: A Latent Class Trajectory Analysis},
journal = {The Journal of Infectious Diseases},
year = {2025},
doi = {10.1093/infdis/jiae349}
}
EUVIMED